Delivery Order SPE2DB20D1100-SPE2DB24FC1G5

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.65 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.54 firm fixed-price delivery order contract is for the provision of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,732.59 delivery order is for the supply of Testosterone Cypionate 200 mg/mL, a prescription pharmaceutical product, to DLA facilities supporting the Department of Defense (DoD). The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award, valued at $2,172.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 24, 2025 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL to the Defense Logistics Agency (DLA). The $1,860.86 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024 with a completion date of December 5, 2024. The contract is not designated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $1,103.74, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,652.80 firm fixed-price contract has a completion date of July 18, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider supplying medical products to federal government agencies, including military and veterans' healthcare systems. This award is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $1,052.14 to supply Testosterone Cypionate 200 mg/ml. The contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range...
This federal contract award, SPE2DX15D1104|SPE2DX24F3HQ6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.36 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL medication. The contract has an ultimate completion date of December 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,053.97 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a prescription medication. The contract does not have a set-aside designation and will have an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded multiple indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC1G5
    Delivery Order

This federal contract award, valued at $1,824.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of testosterone cypionate 200 mg/mL. The contract has a completion date of June 6, 2024 and is a firm fixed-price delivery order.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain capabilities to fulfill a variety of government contracts for essential medical commodities.

Generated 9/4/24, 9:40 AM